| Literature DB >> 34781255 |
Flavia Chechi1, Paola Corsi2, Dario Bartolozzi2, Giovanni Gaiera3, Alessandro Bartoloni1,2,4, Lorenzo Zammarchi1,2,4.
Abstract
The management of visceral leishmaniasis (VL) in HIV-infected patients is complex because of high mortality rates, toxic drug-related side effects, and a high risk of treatment failure and relapse. We report a case of active chronic VL in an HIV-1-infected woman presenting multiple secondary VL episodes over 7 years leading to massive splenomegaly and blood transfusion-dependent anemia despite several treatment courses and secondary prophylaxis. The patient was finally successfully treated with rescue treatment based on intravenous pentamidine. Twenty months after discontinuation of pentamidine the patient presented complete clinical and parasitological response. In patients with active chronic VL, treatment with intravenous pentamidine can be effective and should be considered as rescue treatment.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34781255 PMCID: PMC8832899 DOI: 10.4269/ajtmh.21-0600
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345